New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
09:26 EDTSFY, ARII, AKAM, BMRN, LPSN, HK, AMRN, MA, OTEX, YELP, WFM, YUMOn The Fly: Pre-market Movers
HIGHER: Amarin (AMRN), up 12% after positive mention by Adam Feuerstein of TheStreet. UP AFTER EARNINGS: MasterCard (MA), up 1%... Open Text (OTEX), up 11.5%... LivePerson (LPSN), up 14%... BioMarin (BMRN), up 6.4%... Halcon Resources (HK), up 2.3%... American Railcar (ARII), up 2.5%... Swift Energy (SFY), up 2%. DOWN AFTER EARNINGS: Akamai (AKAM), down 5.2%. LOWER: Whole Foods (WFM), down 5.8% after downgraded at UBS, JPMorgan following the company's lower than expected quarterly earnings results... Yelp (YELP), down 6%, downgraded at Raymond James after the company reported its Q2 results, which included a decline in its newly added businesses... Yum! Brands (YUM), down 6.5% after saying OSI scandal hurt China sales.
News For WFM;YELP;YUM;MA;AMRN;OTEX;LPSN;BMRN;HK;ARII;SFY;AKAM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 20, 2015
19:53 EDTWFMRetailers, others question heightened fees at Port of Oakland, WSJ says
After the Port of Oakland said it is considering implementing additional fees, the Retail Industry Leaders Association told the Federal Maritime Commission that it is "troubled" due to the lack of details regarding the fees, according to the Wall Street Journal. The retailer group also questioned the general effectiveness of such a program, and the Agriculture Transportation Coalition echoed the criticism, said the report. Note that executives from Lowe's (LOW), Best Buy (BBY), Target (TGT), Coca-Cola (KO), J.C. Penney (JCP), Tyson Foods (TSN), SunOpta (STKL), and Whole Foods (WFM) serve on the boards of the aforementioned associations. Reference Link
10:52 EDTWFMWhole Foods calls active
Whole Foods August 33 and 33.5 calls are active on total call volume of 4K contracts (3K puts) on the subject of takeover chatter. August call option implied volatility is at 32, August weekly is at 27, September is at 28; compared to its 52-week range of 17 to 43. Active call volume suggests traders taking positions for large near term price movement.
07:34 EDTAKAMAkamai resumed with an Overweight at Pacific Crest
Subscribe for More Information
August 19, 2015
16:58 EDTYUMOn The Fly: Top stock stories for Wednesday
The market opened deep in negative territory after a tumultuous trading session in China and a softer than expected U.S. consumer prices report. Sellers continued to push the averages lower throughout the morning, with the Dow tacking on losses of more than 200 points as investors waited for the release of the Fed minutes. The market rallied following an early leak of the minutes, which suggested officials are getting closer to raising rates but appear to be waiting for additional data. Despite the afternoon rally, the averages sold off once again heading into the close, leaving all three indices in the negatives for Wednesday. ECONOMIC EVENTS: In the U.S., the July consumer price index edged up 0.1% against expectations for 0.2% reading. The core reading, which excludes food and energy, also came in at 0.1% versus consensus estimates of 0.2%. There were no revisions to the 0.3% headline gain in June or the 0.2% growth in the ex-food and energy component. Component gains were muted across the board, with Energy prices up just 0.1% in July. Meanwhile, FOMC minutes showed no definitive indication of a September rate hike. Most committee members "judged that the conditions for policy firming had not yet been achieved, but they noted that conditions were approaching that point." Other members, however, believed that the inflation outlook "might not soon meet one of the conditions... for initiating a firming of policy." COMPANY NEWS: Shares of Dot Hill Systems (HILL) soared $4.50, or 86.87%, to $9.68 after Seagate Technology (STX) agreed to acquire the company for $9.75 per share, noting that it expects the deal to be non-GAAP EPS accretive in fiscal 2016. Shares of the hard drive giant fell 5.03% to $49.43 for the session... Lowe's (LOW) shares saw gains of $1.34, or 1.84%, to $74.36 following the company's earnings report this morning, while Target (TGT) rose $59c, or 0.73%, to $80.89 after beating on both top and bottom lines. On a subsequent conference call, Target executives forecast a "choppy" competitive environment in Q3, though they added that the company "will not get beat" on promotions in Q4. Separately, American Eagle (AEO) lost 7.42% to $16.92 after its quarterly numbers. MAJOR MOVERS: Among the notable gainers were Palatin (PTN) and Apricus (APRI), showing respective advances of 3.19% and 7.89% after the FDA approved Sprout's female sexual dysfunction drug Addyi, with the agency remarking that it "continues to encourage drug development in this area." Note that both Palatin and Apricus are developing their own treatments in the space, and Apricus reaffirmed this morning its intent to seek a global partner as it advances its Femprox sexual dysfunction medication. Also higher was Yum! Brands (YUM), which gained $1.90, or 2.26%, to $86.10 after appointing a new CEO of its China division, adding that its same-store sales in the region "have turned significantly positive." Among the noteworthy losers was Rayonier Advanced Materials (RYAM), plunging $6.01, or 44.09%, to $7.62 after disclosing a legal battle with its customer Eastman Chemical (EMN) over "meet or release" contract stipulations which may impact Eastman's purchase obligations. Also lower was Caesarstone (CSTE), which lost $3.43, or 7.14%, to $44.61 after short-selling hedge fund Spruce Point said the stock has up to 75% downside due to heightened raw material costs and competitive concerns, among other factors. Separately, EOG Resources (EOG), Baytex Energy (BTE), and Vanguard Natural (VNR) saw respective losses of 4.15%, 15.53%, and 13.83% after WTI crude fell 5.02% for the session. INDEXES: The Dow declined 162.61, or 0.93%, to 17,348.73, the Nasdaq fell 40.30, or 0.80%, to 5,019.05, and the S&P 500 lost 17.31, or 0.83%, to 2,079.61.
16:45 EDTOTEXCaisse de dpt et placement du Qubec reports 5.0% passive stake in OpenText
Subscribe for More Information
16:06 EDTBMRNBioMarin receives rare pediatric disease designation from FDA for drisapersen
Subscribe for More Information
13:23 EDTYUMOptions with increasing call volume
Subscribe for More Information
10:23 EDTYUMYum! gets a boost from China CEO change, sales commentary
Subscribe for More Information
09:19 EDTYUMYum! Brands leadership change positive, says Bernstein
Subscribe for More Information
09:17 EDTBMRN'Female Viagra' approval seen as positive for Sarepta, BioMarin
The FDA's approval of the world's first drug designed to boost a woman's sexual desire is seen as boding well for companies awaiting critical decisions by the agency. FEMALE VIAGRA: The Food and Drug Administration yesterday approved flibanserin to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women. The drug, which will be sold under the name "Addyi" and is commonly referred to as the "female Viagra," is the first FDA-approved treatment for sexual desire disorders in men or women, the agency prominently stated in its press release. HSDD is characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance, the FDA explained. Addyi was approved with a risk evaluation and mitigation strategy as well as a Boxed Warning given the risk of severe hypotension and syncope in patients who drink alcohol during treatment. The drug is made by privately held Sprout Pharmaceuticals. ANALYST REACTION: Addyi's approval is "another sign of flexibility" by the FDA, especially for first-in-class therapies, Roth Capital analyst Debjit Chattopadhyay writes this morning in a note to investors. This bodes well for the approval of eteplirsen, drisapersen and Translarna, the analyst contends. Eteplirsen, designed by Sarepta Therapeutics (SRPT), and drisapersen, designed by BioMarin (BMRN), are experimental drugs being developed to treat Duchenne muscular dystrophy. Translarna, designed by PTC Therapeutics (PTCT), is already being sold in Europe as a treatment for DMD and is awaiting approval from the FDA. Duchenne muscular dystrophy is a form of muscular dystrophy affecting around 1 in 3,600 boys, which results in muscle degeneration and premature death. SAVING LIVES: While female sexual dysfunction is a clinical problem, eteplirsen is designed to save lives, Chattopadhyay points out. He has a Buy rating on Sarepta and noted his price target of $45 assumes accelerated approval for eteplirsen in the first quarter of 2016. Shares of the Massachusetts-based biopharmaceutical company closed yesterday at $35.69.
08:29 EDTBMRNFlibanserin approval bodes well for Sarepta, others, says Roth Capital
Subscribe for More Information
06:21 EDTYELPU.S. government to recognize Yelp ratings on federal agencies, WSJ reports
Under an agreement with Yelp, the U.S. government will recognize the public's ratings on its federal agencies, the Wall Street Journal reports. Reference Link
August 18, 2015
18:32 EDTYUMOn The Fly: After Hours Movers
Subscribe for More Information
16:34 EDTYUMYum! Brands appoints Micky Pant CEO of China Division
Subscribe for More Information
13:01 EDTMAEarnings Watch: Target to report Q2 results after management changes
Subscribe for More Information
10:01 EDTAKAMAkamai management to meet with William Blair
Subscribe for More Information
09:01 EDTMAMasterCard, First Tech Federal announce first U.S. biometric payments pilot
Subscribe for More Information
06:50 EDTAKAMAkamai reports Q2 DDoS attack traffic up 7% vs. Q1
Akamai Technologies announced the availability of the Q2 State of the Internet - Security Report. For the past three quarters, there has been a doubling in the number of DDoS attacks year over year. And while attackers favored less powerful but longer duration attacks this quarter, the number of dangerous mega attacks continues to increase. In Q2, there were 12 attacks peaking at more than 100 Gigabits per second, or Gbps, and five attacks peaking at more than 50 Million packets per second, or Mpps. Very few organizations have the capacity to withstand such attacks on their own. The largest DDoS attack of Q2 measured more than 240 gigabits per second, or Gbps, and persisted for more than 13 hours. Peak bandwidth is typically constrained to a one to two hour window. Q2 also saw one of the highest packet rate attacks ever recorded across the Prolexic Routed network, which peaked at 214 Mpps. That attack volume is capable of taking out tier 1 routers, such as those used by Internet service providers, or ISPs. DDoS attack activity set a new record in Q2 , increasing 132% compared to Q2 of 2014 and increasing 7% compared to Q1. Average peak attack bandwidth and volume increased slightly in Q2 compared to Q1, but remained significantly lower than the peak averages observed in Q2 of 2014. SYN and Simple Service Discovery Protocol, or SSDP, were the most common DDoS attack vectors this quarter - each accounting for approximately 16% of DDoS attack traffic. The proliferation of unsecured home-based, Internet-connected devices using the Universal Plug and Play, or UPnP, Protocol continues to make them attractive for use as SSDP reflectors. Practically unseen a year ago, SSDP attacks have been one of the top attack vectors for the past three quarters. SYN floods have continued to be one of the most common vectors in all volumetric attacks, dating back to the first edition of the security reports in Q3 of 2011. Online gaming has remained the most targeted industry since Q2 of 2014, consistently being targeted in about 35% of DDoS attacks. China has remained the top source of non-spoofed attack traffic for the past two quarters, and has been among the top three source countries since the very first report was issued in Q3 of 2011.
August 17, 2015
13:11 EDTYELPAlibaba unlikely to make competing offer for zulily, say Baird
zulily (ZU) shareholder Alibaba (BABA) is unlikely to make a competing takeover bid for the online retailer, Baird analyst Colin Sebastian tells investors in a research note. Alibaba, which upped its stake in zulily to 9% in May, likely views the company as an investment rather than a vehicle to enter the U.S. market, Sebastian argues. This morning, Liberty Interactive (QVCA) announced it had reached an agreement to acquire zulily for $18.75 per share or $2.4B. The analyst sees strategic benefits from the deal. Increased takeover activity in the small-cap internet space could support the valuations of the remaining independents, including ChannelAdvisor (ECOM), Yelp (YELP), Groupon (GRPN), Angie's List (ANGI) and RetailMeNot (SALE), Sebastian writes. Shares of zulily are soaring 47% to $18.50 following the takeover agreement.
10:55 EDTYUMOptions with increasing implied volatility
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use